Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Bove F, Di Lazzaro G, Mulas D, Cocciolillo F, Di Giuda D, Bentivoglio AR (2018) A role for accelerometry in the differential diagnosis of tremor syndromes. Funct Neurol. 33(1):45–49. https://doi.org/10.11138/fneur/2018.33.1.045
2. Fahn S, Tolosa E (1993) Marín C (1993) Clinical rating scale for tremor. In: Jankovic J, Tolosa E (eds) Parkinson’s Disease and Movement Disorders. Williams and Wilkins, Baltimore, MD, pp 271–280
3. Hagerman R, Hagerman P (2021) Fragile X-associated tremor/ataxia syndrome: pathophysiology and management. Curr Opin Neurol 34(4):541–546. https://doi.org/10.1097/WCO.0000000000000954
4. Apartis E, Blancher A, Meissner WG et al (2012) FXTAS: new insights and the need for revised diagnostic criteria. Neurology 79(18):1898–1907. https://doi.org/10.1212/WNL.0b013e318271f7ff
5. Mittal SO, Pandey S (2022) Botulinum toxin for the treatment of tremor. J Neurol Sci 435:120203. https://doi.org/10.1016/j.jns.2022.120203